EX-FILING FEES

Calculation of Filing Fee Tables

Table 1: Transaction Valuation

		Transaction Valuation	Fee Rate	Amount of Filing Fee
Fees to be Paid	1	$ 3,508,318.05	0.0001381	$ 484.50
Fees Previously Paid
	Total Transaction Valuation:	$ 3,508,318.05
	Total Fees Due for Filing:			$ 484.50
	Total Fees Previously Paid:			$ 0.00
	Total Fee Offsets:			$ 484.50
	Net Fee Due:			$ 0.00

Offering Note

¹	(1) Estimated solely for purposes of calculating the filing fee, based on the cash consideration to be received by the registrant's shareholders in consideration for the transaction converted into United States dollars at an exchange rate of $0.71 per Cdn$1.00 Canadian dollar as computed in accordance with Rule 0-11 (Section 240.0-11(c)(2)) of the Securities Exchange Act of 1934, as amended. (2) In accordance with Section 14(g) of the Exchange Act, the filing fee was calculated by multiplying the aggregate consideration to be received by the registrant determined as described in footnote (1) above by 0.00013810.

Table 2: Fee Offset Claims and Sources	☐Not Applicable

		Registrant or Filer Name	Form or Filing Type	File Number	Initial Filing Date	Filing Date	Fee Offset Claimed	Fee Paid with Fee Offset Source
Fee Offset Claims	1		Schedule 14A	001-32001	12/05/2025		$ 484.50
Fee Offset Sources	2	Aptose Biosciences Inc	Schedule 14A	001-32001		12/05/2025		$ 484.50

Explanation of the basis for claimed offset:

¹	The Company previously paid $484.50 upon the filing of its Schedule 14A on December 5, 2025 in connection with the transaction reported hereby.

Offset Note

²	The Company previously paid $484.50 upon the filing of its Schedule 14A on December 5, 2025 in connection with the transaction reported hereby.